Robert Drysdale tested for elevated levels of testosterone following his bout at The Ultimate Fighter 19 Finale in July and he received a suspension today of one year by the Nevada Athletic Commission.
Along with one year suspension, the commission fined him 33 percent of his purse from the event ($5,280), his submission win over Keith Berish has been overturned to a no contest, and he will need to pass a drug test before coming off suspension.
The suspension was handed down today at the monthly Nevada Athletic Commission, which Drysdale was in attendance.
At the beginning of his hearing, the state presented their case against Drysdale and explained that Drysdale had a 12:1 testosterone to epitestosterone ratio and the legal limit in Nevada is 6:1.
Drysdale was then given an opportunity to present his side of the case. He admitted that in 2013 he was given a prescription for testosterone replacement therapy after he was diagnosed with Hypogonadism by a doctor. He did apply for a therapeutic use exemption for testosterone replacement therapy in 2013, but the commission put a ban on this in February.
After Drysdale gave his side, Commissioner Pat Lundvall questioned him about his pre-fight medical questionnaire. On that document, Drysdale did not mention anything about previously having a prescription of testosterone replacement therapy. The commission would go into deliberation shortly after the questions by Lundvall and Commission Bill Brady filed a motion for the one year suspension, 33 percent fine, Drysdale must pass a drug test, and the win being overturned.
The suspension is retroactive to the July 6th fight and currently, Drysdale is still a member of the UFC roster.